ASX - Delayed Quote AUD

Cynata Therapeutics Limited (CYP.AX)

Compare
0.2300 -0.0100 (-4.17%)
At close: October 25 at 4:10 PM GMT+11
Currency in AUD All numbers in thousands
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Operating Expense
16,655.3190
16,542.5170
13,838.0440
9,080.3830
10,512.4520
Operating Income
-16,655.3190
-16,542.5170
-13,838.0440
-9,080.3830
-10,512.4520
Net Non Operating Interest Income Expense
436.2440
352.8690
64.7490
92.2990
142.3500
Other Income Expense
2,573.4860
1,912.1530
8,328.1230
1,298.4010
6,731.0020
Pretax Income
-13,645.5890
-14,277.4950
-5,445.1720
-7,689.6830
-3,639.1000
Net Income Common Stockholders
-13,645.5890
-14,277.4950
-5,445.1720
-7,689.6830
-3,639.1000
Basic EPS
-0.09
-0.10
-0.04
-0.06
-0.03
Diluted EPS
-0.09
-0.10
-0.04
-0.06
-0.03
Basic Average Shares
163,199.5550
145,092.4170
143,276.5940
130,427.0770
104,822.2160
Diluted Average Shares
163,199.5550
145,092.4170
143,276.5940
130,427.0770
104,822.2160
Net Income from Continuing & Discontinued Operation
-13,645.5890
-14,277.4950
-5,445.1720
-7,689.6830
-3,639.1000
Normalized Income
-13,645.5890
-14,277.4950
-5,445.1720
-7,689.6830
-3,639.1000
Interest Income
436.2440
352.8690
64.7490
92.2990
142.3500
Net Interest Income
436.2440
352.8690
64.7490
92.2990
142.3500
EBIT
-16,655.3190
-16,542.5170
-13,838.0440
-9,080.3830
-10,512.4520
EBITDA
-16,374.9710
-16,262.5520
-13,558.0790
-8,800.4180
-10,231.7200
Reconciled Depreciation
280.3480
279.9650
279.9650
279.9650
280.7320
Net Income from Continuing Operation Net Minority Interest
-13,645.5890
-14,277.4950
-5,445.1720
-7,689.6830
-3,639.1000
Normalized EBITDA
-16,374.9710
-16,262.5520
-13,558.0790
-8,800.4180
-10,231.7200
6/30/2020 - 12/19/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers